Fate Therapeutics, Inc. short interest in 2020
In 2020, Fate Therapeutics, Inc.'s disclosed short interest ran from 12.66% of shares outstanding on 15 Jan 2020 to 12.66% on 31 Dec 2020, a change of +0.00 percentage points. The year's high was 17.13% on 15 Oct 2020 and its low 12.63% on 31 Jan 2020, averaging 14.92% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.86 days on 31 Aug 2020. Full history: Fate Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2020 in figures
- Start of year
- 12.66% (15 Jan 2020)
- End of year
- 12.66% (31 Dec 2020)
- Change
- +0.00 pp
- High
- 17.13% (15 Oct 2020)
- Low
- 12.63% (31 Jan 2020)
- Average
- 14.92%
- Highest days to cover
- 25.86 (31 Aug 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 12.66% | 8.71 | |
| 31 Jan 2020 | 12.63% | 12.50 | |
| 14 Feb 2020 | 12.81% | 15.40 | |
| 28 Feb 2020 | 13.40% | 10.33 | |
| 13 Mar 2020 | 13.73% | 7.80 | 10-K filed, results (8-K) |
| 31 Mar 2020 | 14.92% | 8.83 | |
| 15 Apr 2020 | 15.33% | 8.36 | |
| 30 Apr 2020 | 15.38% | 16.74 | |
| 15 May 2020 | 15.60% | 13.65 | 10-Q filed, results (8-K) |
| 29 May 2020 | 14.83% | 12.03 | |
| 15 Jun 2020 | 14.48% | 7.22 | |
| 30 Jun 2020 | 16.30% | 11.22 | |
| 15 Jul 2020 | 16.15% | 17.82 | |
| 31 Jul 2020 | 16.06% | 24.57 | |
| 14 Aug 2020 | 14.23% | 20.77 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 14.61% | 25.86 | |
| 15 Sep 2020 | 14.88% | 14.85 | |
| 30 Sep 2020 | 16.01% | 11.95 | |
| 15 Oct 2020 | 17.13% | 19.23 | |
| 30 Oct 2020 | 16.52% | 18.02 | |
| 13 Nov 2020 | 16.36% | 21.81 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 16.50% | 22.89 | |
| 15 Dec 2020 | 14.99% | 6.34 | |
| 31 Dec 2020 | 12.66% | 11.81 |
See also: Fate Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.